290 filings
8-K
RENB
Renovaro Inc.
30 Apr 24
Other Events
4:49pm
8-K
RENB
Renovaro Inc.
24 Apr 24
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
5:56pm
8-K/A
RENB
Renovaro Inc.
24 Apr 24
Financial Statements and Exhibits
5:23pm
8-K
RENB
Renovaro Inc.
13 Mar 24
Departure of Directors or Certain Officers
9:30am
8-K
RENB
Renovaro Inc.
7 Mar 24
Termination of a Material Definitive Agreement
5:00pm
8-K
pxwsvft7zghaip90hy8z
5 Mar 24
Departure of Directors or Certain Officers
5:03pm
D
9tsn ie0hkqbi6its4u
23 Feb 24
Exempt offering of security
4:04pm
8-K
7bqr d44ud2hga1
16 Feb 24
Other Events
8:35am
8-K
jm7j 7l4y
14 Feb 24
Entry into a Material Definitive Agreement
4:33pm
8-K
6p0co uenmu5g32ubaou
7 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:51pm
8-K
e0x56g2 35vfnxy7wbhj
25 Jan 24
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
5:15pm
DEFA14A
17m54zcowv xmvtgbb
16 Jan 24
Additional proxy soliciting materials
5:25pm
8-K
5kwlqsn8heij68ntx
16 Jan 24
Other Events
5:23pm
8-K
bsq14g
16 Jan 24
Other Events
8:06am
DEFA14A
jfrrr6utf9bpp0j
16 Jan 24
Additional proxy soliciting materials
8:05am
DEFM14A
438ol e7x8hpapyipec
3 Jan 24
Proxy related to merger
8:00am
PREM14A
ozo jyulwwpmok7l
22 Dec 23
Preliminary proxy related to merger
5:25pm
DEFA14A
snzzeym mro5dey3vfk
22 Dec 23
Additional proxy soliciting materials
11:57am
DEFA14A
6k76728u yp9
11 Dec 23
Additional proxy soliciting materials
5:15pm